Top Broker Regulation Stories
Merck settles investor suits on cholesterol drugs
By Associated PressMerck & Co. has agreed to pay $688 million to settle two lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales.
